1. Home
  2. INSG vs NTHI Comparison

INSG vs NTHI Comparison

Compare INSG & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$10.38

Market Cap

174.9M

ML Signal

HOLD

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$9.69

Market Cap

195.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
NTHI
Founded
1996
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.9M
195.5M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
INSG
NTHI
Price
$10.38
$9.69
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$15.50
N/A
AVG Volume (30 Days)
181.8K
66.1K
Earning Date
02-18-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$165,876,000.00
$59,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
$13.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.24
$3.20
52 Week High
$18.11
$25.00

Technical Indicators

Market Signals
Indicator
INSG
NTHI
Relative Strength Index (RSI) 42.05 60.64
Support Level $9.87 $8.11
Resistance Level $10.97 $10.71
Average True Range (ATR) 0.45 0.79
MACD 0.02 0.20
Stochastic Oscillator 38.46 83.53

Price Performance

Historical Comparison
INSG
NTHI

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: